Literature DB >> 11179772

Molecular evolution of proglucagon.

D M Irwin1.   

Abstract

The vertebrate proglucagon gene encodes glucagon, and the two glucagon-like peptides GLP-1 and GLP-2. To better understand the origin and diversification of the distinct hormonal roles of the three glucagon-like sequences encoded by the proglucagon gene, we have examined the evolution of this gene. The structure of proglucagon has been largely maintained within vertebrates. Duplication of the proglucagon gene or duplications of sequences within the proglucagon gene are rare. All proglucagon gene duplications are likely to be the result of genome duplication events. Examination of the rates of amino acid sequence evolution of each hormone reveals that they have not evolved in a uniform manner. Each hormone has evolved in an episodic fashion, suggesting that the selective constraints acting upon the sequence vary between, and within, vertebrate classes. Changes in selection on a sequence often reflect changes in the function of the sequence, such as the change in function of GLP-1 from a glucagon-like hormone in fish to an incretin in mammals. We found that the GLP-2 sequence underwent rapid sequence evolution in the early mammal lineage, therefore we have concluded that mammalian GLP-2 has acquired a new biological function that is not found in other vertebrates. Comparisons of the hormone sequences show that many amino acid residues that are functionally important in mammalian hormones are not conserved through vertebrate evolution. This observation suggests that the sequences involved in hormone action change through evolution.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179772     DOI: 10.1016/s0167-0115(00)00232-9

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  14 in total

1.  The human Hox-bearing chromosome regions did arise by block or chromosome (or even genome) duplications.

Authors:  Dan Larhammar; Lars-Gustav Lundin; Finn Hallböök
Journal:  Genome Res       Date:  2002-12       Impact factor: 9.043

Review 2.  Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies.

Authors:  Megan C Chapter; Caitlin M White; Angela DeRidder; Wayne Chadwick; Bronwen Martin; Stuart Maudsley
Journal:  Pharmacol Ther       Date:  2009-08-15       Impact factor: 12.310

3.  A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells.

Authors:  Y Hattori; T Jojima; A Tomizawa; H Satoh; S Hattori; K Kasai; T Hayashi
Journal:  Diabetologia       Date:  2010-07-01       Impact factor: 10.122

4.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

5.  Two dipolar α-helices within hormone-encoding regions of proglucagon are sorting signals to the regulated secretory pathway.

Authors:  Leonardo Guizzetti; Rebecca McGirr; Savita Dhanvantari
Journal:  J Biol Chem       Date:  2014-04-11       Impact factor: 5.157

Review 6.  Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation.

Authors:  G-R Martin; P-L Beck; D-L Sigalet
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

7.  The serendipitous origin of chordate secretin peptide family members.

Authors:  João C R Cardoso; Florbela A Vieira; Ana S Gomes; Deborah M Power
Journal:  BMC Evol Biol       Date:  2010-05-06       Impact factor: 3.260

8.  Liraglutide, a long-acting GLP-1 mimetic, and its metabolite attenuate inflammation after intracerebral hemorrhage.

Authors:  Jack Hou; Anatol Manaenko; Jakob Hakon; Jacob Hansen-Schwartz; Jiping Tang; John H Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2012-09-12       Impact factor: 6.200

9.  Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists.

Authors:  Baptist Gallwitz
Journal:  Rev Diabet Stud       Date:  2009-12-30

Review 10.  Clinical review: The extrapancreatic effects of glucagon-like peptide-1 and related peptides.

Authors:  Rania Abu-Hamdah; Atoosa Rabiee; Graydon S Meneilly; Richard P Shannon; Dana K Andersen; Dariush Elahi
Journal:  J Clin Endocrinol Metab       Date:  2009-03-31       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.